https://ardelyx.com/
Home - Ardelyx
ardelyx
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ardx/ardelyx/ownership
Ardelyx, Inc. Insider Trading & Ownership Structure - Simply Wall St
Uncover the latest insider trading activity for Ardelyx, Inc. (ARDX). Know which insiders are buying and selling along with top shareholders and ownership...
insider tradingownership structureardelyxincsimply
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ardx/ardelyx/news/earnings-beat-ardelyx-inc-nasdaqardx-just-beat-analyst-forec
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been...
Ardelyx, Inc. ( NASDAQ:ARDX ) just released its latest second-quarter results and things are looking bullish. The...
https://www.macrotrends.net/stocks/charts/ARDX/ardelyx/number-of-employees
Ardelyx Number of Employees 2013-2026 | ARDX | MacroTrends
Ardelyx number of employees from 2013 to 2026. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus...
ardelyxnumberemployees20132026
https://finviz.com/news/25101/is-ardelyx-inc-nasdaq-ardx-the-best-biotech-penny-stock-to-buy-according-to-hedge-funds
Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Stock screener for investors and traders, financial visualizations.
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ardx/ardelyx/news/ardelyx-first-quarter-2025-earnings-misses-expectations
Ardelyx First Quarter 2025 Earnings: Misses Expectations - Simply Wall St News
Ardelyx ( NASDAQ:ARDX ) First Quarter 2025 Results Key Financial Results Revenue: US$74.1m (up 61% from 1Q 2024). Net...
simply wall stfirst quarterardelyx2025earnings
https://finviz.com/news/341673/rajani-dinavahi-md-appointed-chief-medical-officer-of-ardelyx
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
Stock screener for investors and traders, financial visualizations.
chief medical officerrajanimdappointedardelyx
https://investingnews.com/ardelyx-presents-analysis-supporting-long-term-safety-of-xphozah-at-nkf-s-spring-clinical-meetings/
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical Meetings...
May 7, 2026 - Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet...
https://www.benzinga.com/news/earnings/23/10/35316352/crude-oil-rises-sharply-ardelyx-shares-spike-higher
Crude Oil Rises Sharply; Ardelyx Shares Spike Higher - Ardelyx (NASDAQ:ARDX), Bridger Aerospace...
crude oil
https://finviz.com/quote?t=ARDX&ty=lf&ta=1&p=d
ARDX - Ardelyx Inc Latest SEC Filings
ARDX - Ardelyx Inc - Stock screener for investors and traders, financial visualizations.
ardxardelyxinclatestsec
https://finviz.com/quote?t=ARDX&ta=1&p=d&ty=tr
ARDX - Ardelyx Inc Website Traffic and Mobile Apps Usage
ARDX - Ardelyx Inc - Stock screener for investors and traders, financial visualizations.
website trafficmobile appsardxardelyxinc
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ardx/ardelyx/health
Ardelyx (ARDX) Balance Sheet & Financial Health Metrics - Simply Wall St
Discover Ardelyx's balance sheet and financial health metrics. From total debt, total equity, assets to cash-on-hand, interest coverage and more.
balance sheetfinancial healthardelyxardxmetrics
https://www.globenewswire.com/news-release/2025/04/24/3067378/0/en/Ardelyx-Announces-Three-Abstracts-Accepted-for-Poster-Presentations-at-Digestive-Disease-Week-2025-Conference.html
Ardelyx Announces Three Abstracts Accepted for Poster
WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...
ardelyxannouncesthreeabstractsaccepted
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ardx/ardelyx/news/ardelyx-incs-nasdaqardx-business-is-yet-to-catch-up-with-its
Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price - Simply Wall St News
There wouldn't be many who think Ardelyx, Inc.'s ( NASDAQ:ARDX ) price-to-sales (or "P/S") ratio of 10.6x is worth a...
https://www.benzinga.com/news/earnings/21/07/22063228/mid-morning-market-update-markets-open-higher-philip-morris-posts-mixed-q2-results
Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results - Ardelyx...
https://www.benzinga.com/news/earnings/22/04/26797329/mid-afternoon-market-update-nasdaq-rises-70-points-eliem-therapeutics-shares-slide
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide - Ardelyx...
Apr 25, 2022 - U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.
https://finviz.com/news/62655/ardelyx-to-participate-at-the-jefferies-global-healthcare-conference-2025
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025
Stock screener for investors and traders, financial visualizations.
to participateglobal healthcareardelyxjefferiesconference
https://www.home.saxo/fr-be/markets/stocks/ardx-xnas
Ardelyx Inc. action | Saxo Bank
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs.
ardelyxincactionsaxobank
https://www.macrotrends.net/stocks/charts/ARDX/ardelyx/price-book
Ardelyx Price to Book Ratio 2013-2026 | ARDX | MacroTrends
price to book ratioardelyx20132026ardx
https://www.nasdaq.com/market-activity/stocks/ardx
Ardelyx, Inc. Common Stock (ARDX) Stock Price, Quote, News & History | Nasdaq
Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions....
common stockprice quotenews historyardelyxinc
https://www.prnewswire.com/news-releases/ardx-investors-have-opportunity-to-lead-ardelyx-incsecurities-fraud-lawsuit-with-the-schall-law-firm-302271066.html
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law...
/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc....
https://www.home.saxo/fr-fr/markets/stocks/ardx-xnas
Ardelyx Inc. action | Saxo Banque
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs.
ardelyxincactionsaxobanque
https://finviz.com/news/329301/ardelyx-to-participate-in-upcoming-investor-conferences
Ardelyx to Participate in Upcoming Investor Conferences
Stock screener for investors and traders, financial visualizations.
to participateardelyxupcominginvestorconferences
https://finviz.com/news/282198/strength-seen-in-ardelyx-ardx-can-its-150-jump-turn-into-more-strength
Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength?
Stock screener for investors and traders, financial visualizations.
https://finviz.com/news/316426/ardelyx-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Stock screener for investors and traders, financial visualizations.
2025 financial results
https://investingnews.com/ardelyx-reports-first-quarter-2026-financial-results-and-provides-business-update/
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update | INN
Apr 30, 2026 - Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year IBSRELA Q1 2026 revenue growth of 58% year-over-year to $70.1 million;...
first quarter 2026financial results
https://www.biospace.com/press-releases/ardelyx-to-present-at-the-td-cowen-45th-annual-health-care-conference
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference - BioSpace
https://www.benzinga.com/general/biotech/21/07/22057476/the-daily-biotech-pulse-ardelyx-sinks-on-regulatory-setback-anpac-issues-positive-preannouncement
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive...
Jul 20, 2021 - Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)
the daily
https://www.globenewswire.com/news-release/2024/09/28/2954765/673/en/ROSEN-A-LONGSTANDING-LAW-FIRM-Encourages-Ardelyx-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-ARDX.html
ROSEN, A LONGSTANDING LAW FIRM, Encourages Ardelyx, Inc.
NEW YORK, Sept. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardelyx, Inc....
law firmrosenencouragesardelyxinc